Literature DB >> 11434784

Equilibrative nucleoside transporters: mapping regions of interaction for the substrate analogue nitrobenzylthioinosine (NBMPR) using rat chimeric proteins.

M Sundaram1, S Y Yao, A M Ng, C E Cass, S A Baldwin, J D Young.   

Abstract

The rat equilibrative nucleoside transporters rENT1 and rENT2 belong to a family of integral membrane proteins with 11 potential transmembrane segments (TMs) and are distinguished functionally by differences in sensitivity to inhibition by nitrobenzylthioinosine (NBMPR). Structurally, the proteins have a large glycosylated extracellular loop between TMs 1 and 2 and a large cytoplasmic loop between TMs 6 and 7. In the present study, we have generated chimeras between NBMPR-sensitive rENT1 and NBMPR-insensitive rENT2, using splice sites at rENT1 residues 99 (end of TM 2), 171 (between TMs 4 and 5), and 231 (end of TM 6) to identify structural domains of rENT1 responsible for transport inhibition by NBMPR. Transplanting the amino-terminal half of rENT2 into rENT1 rendered rENT1 NBMPR-insensitive. Domain swaps within the amino-terminal halves of rENT1 and rENT2 identified two contiguous regions, TMs 3-4 (rENT1 residues 100-171) and TMs 5-6 (rENT1 residues 172-231), as the major sites of NBMPR interaction. Since NBMPR is a nucleoside analogue and functions as a competitive inhibitor of zero-trans nucleoside influx, TMs 3-6 are likely to form parts of the substrate translocation channel.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11434784     DOI: 10.1021/bi0101805

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  An ab Initio structural model of a nucleoside permease predicts functionally important residues.

Authors:  Raquel Valdés; Shirin Arastu-Kapur; Scott M Landfear; Ujwal Shinde
Journal:  J Biol Chem       Date:  2009-05-08       Impact factor: 5.157

Review 2.  Equilibrative nucleoside transporters-A review.

Authors:  Rebba C Boswell-Casteel; Franklin A Hays
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2016-10-19       Impact factor: 1.381

Review 3.  Purine import into malaria parasites as a target for antimalarial drug development.

Authors:  I J Frame; Roman Deniskin; Avish Arora; Myles H Akabas
Journal:  Ann N Y Acad Sci       Date:  2014-11-25       Impact factor: 5.691

Review 4.  The equilibrative nucleoside transporter family, SLC29.

Authors:  Stephen A Baldwin; Paul R Beal; Sylvia Y M Yao; Anne E King; Carol E Cass; James D Young
Journal:  Pflugers Arch       Date:  2003-06-28       Impact factor: 3.657

5.  Cysteine cross-linking defines the extracellular gate for the Leishmania donovani nucleoside transporter 1.1 (LdNT1.1).

Authors:  Raquel Valdés; Ujwal Shinde; Scott M Landfear
Journal:  J Biol Chem       Date:  2012-11-13       Impact factor: 5.157

Review 6.  Concentrative nucleoside transporters (CNTs) in epithelia: from absorption to cell signaling.

Authors:  M Pastor-Anglada; E Errasti-Murugarren; I Aymerich; F J Casado
Journal:  J Physiol Biochem       Date:  2007-03       Impact factor: 4.158

7.  Mutation of leucine-92 selectively reduces the apparent affinity of inosine, guanosine, NBMPR [S6-(4-nitrobenzyl)-mercaptopurine riboside] and dilazep for the human equilibrative nucleoside transporter, hENT1.

Authors:  Christopher J Endres; Dhruba J Sengupta; Jashvant D Unadkat
Journal:  Biochem J       Date:  2004-05-15       Impact factor: 3.857

8.  Structure-Activity Relationship Studies of 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine (FPMINT) Analogues as Inhibitors of Human Equilibrative Nucleoside Transporters.

Authors:  Renkai Li; Winston Wing-Shum Mak; Jingjing Li; Chengwen Zheng; Polly Ho-Ting Shiu; Sai-Wang Seto; Simon Ming-Yuen Lee; George Pak-Heng Leung
Journal:  Front Pharmacol       Date:  2022-02-21       Impact factor: 5.810

9.  Testicular disposition of clofarabine in rats is dependent on equilibrative nucleoside transporters.

Authors:  Siennah R Miller; Joseph L Jilek; Meghan E McGrath; Raymond K Hau; Erin Q Jennings; James J Galligan; Stephen H Wright; Nathan J Cherrington
Journal:  Pharmacol Res Perspect       Date:  2021-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.